rosiglitazone has been researched along with Symptom Cluster in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (80.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cherian-Shaw, M; Hammock, BD; Hye Khan, MA; Imig, JD; Nagasawa, T; Shaw, SM; Walsh, KA | 1 |
Leiter, EH; Mistry, J; Pan, HJ; Reifsnyder, PC; Xiao, Q; Zhang, W | 1 |
Anhalt, H; Bhangoo, A; Collin, GB; Maclaren, N; Marshall, JD; Naggert, JK; Sinha, SK; Ten, S | 1 |
Atabek, ME | 1 |
Braun, M; Brenner, RE; Debatin, KM; Hauner, H; Heinze, E; Melzner, I; Möller, P; Wabitsch, M | 1 |
5 other study(ies) available for rosiglitazone and Symptom Cluster
Article | Year |
---|---|
Soluble epoxide hydrolase inhibition and peroxisome proliferator activated receptor γ agonist improve vascular function and decrease renal injury in hypertensive obese rats.
Topics: Albuminuria; Animals; Blood Pressure; Cardiomegaly; Epoxide Hydrolases; Hypertension; Hypoglycemic Agents; Kidney Glomerulus; Macrophages; Male; Obesity; PPAR gamma; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Rosiglitazone; Species Specificity; Syndrome; Thiazolidinediones | 2012 |
Differential endocrine responses to rosiglitazone therapy in new mouse models of type 2 diabetes.
Topics: Adiponectin; Analysis of Variance; Animals; Biomarkers; Diabetes Mellitus, Type 2; Disease Models, Animal; Fatty Liver; Female; Glucose Intolerance; Hypoglycemic Agents; Insulin; Leptin; Male; Mice; Mice, Congenic; Mice, Inbred NOD; Mice, Obese; Obesity; Phenotype; Plasminogen Activator Inhibitor 1; Quantitative Trait, Heritable; Recombination, Genetic; Resistin; Rosiglitazone; Species Specificity; Syndrome; Thiazolidinediones | 2006 |
Effect of metformin and rosiglitazone in a prepubertal boy with Alström syndrome.
Topics: Abnormalities, Multiple; Child; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Fatty Liver; Humans; Hypoglycemic Agents; Insulin Resistance; Male; Metformin; Obesity; Rosiglitazone; Syndrome; Thiazolidinediones | 2007 |
Re: "Effect of metformin and rosiglitazone in a prepubertal boy with Alström syndrome", Sinha SK et al., JPEM 2007; 20: 1045-1052.
Topics: Child; Deafness; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Humans; Hypoglycemic Agents; Male; Metformin; Nystagmus, Congenital; Obesity; Retinitis Pigmentosa; Rosiglitazone; Syndrome; Thiazolidinediones | 2008 |
Characterization of a human preadipocyte cell strain with high capacity for adipose differentiation.
Topics: Adipocytes; Adipose Tissue; Cell Differentiation; Cell Division; Cells, Cultured; Female; Gene Expression; Glypicans; Growth Disorders; Heparan Sulfate Proteoglycans; Humans; Infant; Insulin; Karyotyping; Leptin; Male; Models, Biological; Receptors, Cytoplasmic and Nuclear; Rosiglitazone; Syndrome; Thiazoles; Thiazolidinediones; Transcription Factors | 2001 |